Vascepa is a prescription medication that contains the active ingredient icosapent ethyl, which is used to treat high levels of triglycerides in the blood. According to the sources provided, Vascepa is not currently available for purchase in Canada.

The drugpatentwatch.com website [1] indicates that the patent for Vascepa is set to expire in 2030, but it does not provide any information on the availability of the drug in Canada.

The official Vascepa website [2] states that the medication is currently only available in the United States, where it has been approved by the Food and Drug Administration (FDA) for use in treating patients with high triglyceride levels. The website does not provide any information on when or if Vascepa will become available in Canada.

A publication on the National Center for Biotechnology Information (NCBI) website [3] also notes that Vascepa is not currently available in Canada, but it suggests that patients with high triglyceride levels may be able to use other medications that are available in Canada, such as omega-3 fatty acid supplements or prescription medications like Lovaza.

In conclusion, based on the sources provided, it appears that Vascepa is not currently available for purchase in Canada. Patients with high triglyceride levels in Canada may want to speak with their healthcare provider about alternative treatment options that are available in the country.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.vascepa.com/
[3] https://www.ncbi.nlm.nih.gov/books/NBK566005/